Synthon Competitors and Similar CompaniesClear all
Synthon's competitors and similar companies include Amphastar Pharmaceuticals, Genentech, Cipla and EMS Pharma.
 Synthon Synthon is a pharmaceutical company that develops, manufactures, and commercializes generic medicines. |  Amphastar Pharmaceuticals Amphastar Pharmaceuticals is a pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal, and inhalation products. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | |
Founding Date | Founding Date 1991 | Founding Date 1996 | Founding Date 1976 | Founding Date 1935 | Founding Date 1964 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Rancho Cucamonga, US HQ Nanjing Shi, CN | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations BR HQ | |
Employees | Employees 1,3301% increase | Employees 1,7619% increase | Employees 18,077 | Employees 27,764 | Employees 12,7441% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $719.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $363.8m (FY, 2025) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $356.1m (FY, 2025) | Gross profit N/A | Gross profit ₹195b (FY, 2026) | Gross profit N/A |
Net income | Net income N/A | Net income $98.1m (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income N/A |
Operating ⚠ | |||||
Products | Products N/A | Products 20 (Q3, 2021) | Products N/A | Products 1.5 k (FY, 2024) | Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Amphastar Pharmaceuticals
HQ
Rancho Cucamonga, US
Employees
1,761↑ 9% increase
Amphastar Pharmaceuticals is a pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal, and inhalation products.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company